Pharmaceutical Technology's Equipment and Machinery Spending Survey - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Pharmaceutical Technology's Equipment and Machinery Spending Survey
The pharmaceutical industry plans moderate increases in spending for equipment and machinery in 2007 as expenditures hold steady.

Pharmaceutical Technology


The results of Pharmaceutical Technology's Equipment and Machinery Spending Survey show that spending on pharmaceutical equipment and equipment is holding steady for 2007, with moderate increases planned for this year. The survey gauges spending levels and factors influencing spending for machinery and equipment used in pharmaceutical manufacturing.

For purposes of the survey, machinery and equipment refers to equipment and machinery for solid-dosage, aseptic, sterile, parenteral, active pharmaceutical ingredient manufacturing, quality control and assurance (including analytical instrumentation and laboratory equipment), process control and automation, pharmaceutical packaging, and environmental control.


Respondents profile
The survey (see sidebar, "Respondents' profile") was targeted at individuals with responsibility for purchasing, authorizing purchasing, or reviewing purchasing for equipment and machinery for a pharmaceutical company.

Spending increases slow

The survey asked respondents whether their companies plan to increase spending on machinery and equipment in 2007 and whether they increased spending in 2006 and 2005 (see Figure 1). In 2006 and 2005, the number of respondents increasing spending was fairly consistent: 59.2% in 2006 and 63.3% in 2005. For 2007, however, only 40.8% of respondents said they plan to increase spending, and 26.5% do not plan to increase spending in 2007.


Figure 1: (see pie charts on this page): Spending increases on pharmaceutical machinery and equipment: planned for 2007, in 2006, and in 2005.























Levels of spending


Figure 2
To gauge the level of spending on equipment and machinery, the survey asked participants to estimate their companies' spending as a percentage of overall revenues (see Figure 2) and in absolute amounts (see Figure 3).

In estimating spending for 2007, 29.8% of respondents say their companies plan to spend between 2.1–4% of their overall revenues on equipment and machinery and 25.5% plan to spend 0.1–2% of their overall revenues on equipment and machinery (see Figure 2). In 2006, only 16.3% of respondents said their companies spent 2.1–4% of their overall revenues on equipment and machinery.


ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
FDASIA was signed into law two years ago. Where has the most progress been made in implementation?
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
Reducing drug shortages
70%
Breakthrough designations
4%
Protecting the supply chain
17%
Expedited reviews of drug submissions
2%
More stakeholder involvement
7%
View Results
Eric Langerr Outsourcing Outlook Eric LangerTargeting Different Off-Shore Destinations
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerAsymmetric Synthesis Continues to Advance
Jill Wechsler Regulatory Watch Jill Wechsler Data Integrity Key to GMP Compliance
Sean Milmo European Regulatory WatchSean MilmoExtending the Scope of Pharmacovigilance Comes at a Price
From Generics to Supergenerics
CMOs and the Track-and-Trace Race: Are You Engaged Yet?
Ebola Outbreak Raises Ethical Issues
Better Comms Means a Fitter Future for Pharma, Part 2: Realizing the Benefits of Unified Communications
Better Comms Means a Fitter Future for Pharma, Part 1: Challenges and Changes
Source: Pharmaceutical Technology,
Click here